Syndax Announces Presentation at 42nd Annual J.P. Morgan Healthcare Conference

Syndax Pharmaceuticals , a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, will present at the 42nd Annual J.P. Morgan...

Related Keywords

Michaela Metzger ,Sharon Klahre ,Prnewswire Syndax Pharmaceuticals Nasdaq ,Syndax Pharmaceuticals ,Syndax Pharmaceuticals Inc ,Announces Presentation ,Chief Executive Officer ,Healthcare Conference ,